In an underground auditorium packed with thousands of health-care executives this week, Epic Systems CEO Judy Faulkner stepped on stage to deliver a keynote dressed like a swan, feathers and all.
Even by the tech industry’s more casual standards (take Nvidia CEO Jensen Huang’s trademark leather jacket, for instance), Faulkner’s costume may have puzzled some first-time attendees. But for many health-care industry veterans and Epic employees, it was business as usual— a sign that Epic’s annual Users Group Meeting was officially underway. And one theme stood out during the health-care company’s event on Tuesday: How new artificial intelligence features can help doctors and patients.
Epic is a health-care software giant whose technology is used in thousands of U.S. hospitals and clinics. The company houses medical records for more than 280 million individuals in the U.S., though patients often have data stored across multiple vendors.
Wizards and animals
Each year, thousands of people descend on Epic’s headquarters in Verona, Wisconsin to hear about its latest products and initiatives. UGM is one of the company’s largest annual on-campus events, and CNBC attended the festivities on Tuesday.
Epic’s 1,670-acre campus is sprinkled with farm animals, statues of wizards and buildings themed like “Alice in Wonderland” and “The Wizard of Oz.” Fittingly, this year’s conference is “storytime” themed, and Faulkner and other Epic executives spoke while dressed as characters inspired by various children’s books.
There was no shortage of skits and jingles as they shared updates across Epic’s major products, including its offerings like MyChart, an app patients can use to access their medical records, and Cosmos, a deidentified patient dataset clinicians can use to conduct research.
Seth Hain, senior vice president of R&D at Epic, speaking at UGM 2024.
Courtesy: Epic Systems
Epic’s Artificial Intelligence announcements
Many of Epic’s announcements centered around how the company is integrating artificial intelligence into these products. Faulkner said the company has more than 100 AI features in the works, though many of the tools are still in the early stages of development.
For instance, by the end of this year, Epic said its generative AI will help doctors revise message responses, letters and instructions into plain language that patients can understand. Doctors will be able to use AI to automatically queue up orders for prescriptions and labs, the company said.
Many physicians have to carry out time-consuming tasks like drafting insurance denial appeal letters and reviewing prior authorization requirements, so Epic said it is working to introduce AI tools that can streamline those processes this year.
By the end of 2025, Epic’s generative AI will be able to pull in the results, medications and other details that a doctor might need when responding to a patient’s message through MyChart, the company said. Other specific functions, like using AI to calculate wound measurements from images, are also coming next year.
Epic announced plans for a new staff scheduling application for physicians and nurses called “Teamwork” that’s coming soon. Additionally, Faulkner said Epic is “investigating” how it could facilitate claims submissions directly through its software, without the need for a middleman like a clearinghouse. If Epic is successful, it could mark a major change in the way that insurance claims are processed throughout the health-care industry.
Whether these features will all come to fruition — and whether health systems will actually use them — isn’t yet known. Even so, Epic closed its presentation Tuesday by showcasing a lofty demo about where the company believes its technology can go.
The future
Seth Hain, senior vice president of research and development at Epic, facilitated the demo. He spoke to an AI agent through the MyChart app about his recovery after a supposed wrist surgery and answered questions about his pain. The agent instructed Hain to open his camera and bend his wrist back so it could evaluate the progress of his healing. The agent said Hain’s wrist extension was about 60 to 75 degrees, which meant his recovery was ahead of schedule, compared to data from similar patients in Epic’s Cosmos database.
Hain asked the agent if he could start playing pickleball again, and it told him that he “should still wait a little longer” before doing so.
In a meeting with reporters after the presentation, Hain said the demo was happening in real-time without human intervention. However, that capability is so new that Epic doesn’t even have a name for it yet, and Hain said it will likely be a few years before it’s more widely available.
“It is very, very, very early in regards to how and where the community, the broader medical community, will adopt that type of thing, but it’s viable,” he said.
CNBC’s Jim Cramer suggested Wall Street is too fixated the on large valuations of certain tech and speculative stocks, chalking up Tuesday’s market-wide decline in part to Palantir‘s nearly 8% loss despite strong earnings results.
“The larger issue is that we’re at the moment where money managers, when asked if the market’s too expensive, immediately think of the high-flying speculative stocks or those in the high-growth artificial intelligence column, and so they warn you away from the entire asset class,” he said. “These guys don’t think of the other 334 stocks in the S&P 500 that sell for less than 23 times earnings — those aren’t outrageous.”
Declines in Palantir and other artificial intelligence companies helped bring stocks down on Tuesday, with the S&P 500 losing 1.17%,the Dow Jones Industrial Average shedding 0.53% and the tech-heavy Nasdaq Composite sinking 2.04%. Palantir managed to beat the estimates and offer solid guidance, citing growth in the artificial intelligence business. But investors worried broadly about the huge valuations of tech giants that have been leading the market to new heights.
Investors who saw Palantir as their “north star” were alarmed by its big pullback after a great quarter, according to Cramer. The fears triggered “a raft of selling” as these investors questioned the market as a whole, he continued.
Palantir can be a tough stock to classify, Cramer suggested, saying it straddles two different market segments — one centered around tech and artificial intelligence, and another focused on speculative stocks. He noted that the data-driven software company is very lucrative and fast growing, and it “defies easy description.” He listed off a number of its business arms — including its work as a defense contractor and as a consultant for companies looking to modernize and improve profitability.
To Cramer, it’s reasonable to consider that there’s nothing wrong with Palantir, and it just needs “to cool off in order to grow into its market capitalization.”
“Sure, there are indeed some stocks that are visibly overvalued, and when you pull them apart, many of these valuations can be justified, some can’t,” he said. “I think the Magnificent Seven can be justified on the pace of the growth that’s ahead of them. Same, ultimately, with Palantir.”
Bitcoin‘s fall below $100,000, its lowest level since June, has sparked fears that the worst is yet to come, another so-called crypto winter (a prolonged bear market in cryptocurrencies) that the market wrestles with every time digital currencies sell off hard in a short period of time.
But Bitwise chief investment officer Matt Hougan says that while the retail investor is in “max desperation” mode, he sees that as a reason to bet that a bottoming in crypto prices may materialize sooner rather than later. With Wall Street institutional investor and financial advisor support for bitcoin, and growth in crypto ETFs, he is even willing to go out on a limb and say that amid the heavy selling a new record high for bitcoin before the end of the year isn’t unreasonable.
“It’s almost a tale of two markets,” he said on CNBC’s “Crypto World” on Tuesday. “Crypto retail is in max desperation. We’ve seen leverage blowouts. … the market for sort of crypto native retail is just more depressed than I’ve ever seen it,” he said.
But Hougan believes more crypto trading will continue to shift into an institutionally driven market, “and interestingly, that market is still bullish,” he said.
“When I go out and speak to institutions or financial advisors, they’re still excited to allocate to an asset class that if you pan back and look over the course of a year, is still delivering very strong returns. So my view of the market is we have to get through this retail flush out. We have to hit bottom from a sentiment perspective. I think we’re very close to that,” he added.
Stock Chart IconStock chart icon
Price of bitcoin and ether over the past year.
The boom in crypto exchange-traded fund launches, including iShares Bitcoin Trust (IBIT) and the Fidelity Wise Origin Bitcoin Fund (FBTC) and Grayscale Bitcoin Trust (GBTC) is changing the investor composition, and while week-to-week flows into these ETFs have slowed since the second quarter of the year, “we continue to see strong inflows into bitcoin,” Hougan said.
Bitwise’s own Solana staking ETF (BSOL) brought in over $400 million in flows in its first week, he said, though it has sold off sharply in the recent crypto downturn, with a near 20% loss since its Oct. 28 debut.
Stock Chart IconStock chart icon
This chart is showing BSOL 5 days
Last week, Strategy CEO Michael Saylor told CNBC he thinks bitcoin could reach $150,000 by the end of the year, one among several recent bullish calls on crypto that for now at least look ill-timed. But Hougan said he doesn’t think it’s an outlandish call even as bitcoin hovers near a six-month low.
“I think bitcoin could easily end the year at new all-time highs,” Hougan said. “So that means getting north of about $125,000 up to $130,000. Whether we’ll get all the way to $150,000, we’ll have to see.”
“I do think the sellers are nearing exhaustion and the buyers are still relatively hungry. And when those two things sort of cross paths, again, I think we could end the year close to or at new all-time highs. And if we’re lucky, we’ll get to Saylor’s target as well,” he said.
Institutional investors, whom Hougan described as “more maybe even keeled about what’s going on at a fundamental level in crypto” will start to drive the market forward. “But we do have to finish this washout of retail sentiment … I think we’re closer to the end of that than the beginning, but … there always could be a little bit more downside.”
Jared Isaacman, U.S. President Donald Trump’s nominee to be administrator of the National Aeronautics and Space Administration (NASA) testifies during a Senate Commerce, Science, and Transportation confirmation hearing on Capitol Hill in Washington, D.C., U.S., April 9, 2025.
Ken Cedeno | Reuters
President Donald Trump has renominated Jared Isaacman to run NASA after pulling his prior nomination months ago due to what the president called a “thorough review of prior associations.”
“Jared’s passion for Space, astronaut experience, and dedication to pushing the boundaries of exploration, unlocking the mysteries of the universe, and advancing the new Space economy, make him ideally suited to lead NASA into a bold new Era,” Trump wrote in a post on Truth Social on Tuesday.
Isaacman, who is friends with Tesla CEO Elon Musk, was originally picked to lead NASA in December, before Trump had even taken office. Isaacman is a billionaire who founded payments company Shift4 and has led two private spaceflights.
But Trump pulled the nomination in late May after a spat between the president and Musk, who had been leading a White House effort to slash the size of the federal government. Trump said at the time that he was withdrawing the pick because of Isaacman’s past associations, though he didn’t specify what those were. Some reports have suggested that it was a reference to Isaacman’s prior donations to Democrats.
Days after the withdrawal, Isaacman told Shift4 investors in a letter that his “brief stint in politics was a thrilling experience.” He also said that he was resigning as CEO of Shift4, which he founded in 1999 at age 16, and would assume the role of executive chairman. He had been planning to leave the company if his nomination was confirmed by the Senate. But it never got that far.
Transportation Secretary Sean Duffy has been running NASA as interim head since July.
Isaacman still must go through the Senate confirmation process. The federal government has been shut down since the beginning of October, but the Senate is still able to confirm presidential nominees.